| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 06/12/2003 | WO2003048112A1 Aminoacetonitrile derivatives and their use for controlling parasites |
| 06/12/2003 | WO2003047617A2 Vaccine |
| 06/12/2003 | US20030109702 Fungicides, bactericides |
| 06/12/2003 | US20030109671 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 06/12/2003 | US20030109565 Administered by any means other than orally, characterized in that it comprises xylitol, and more particularly to an antipyretic preparation characterized in that it consists of an antipyretic and a synergistic amount of xylitol. |
| 06/12/2003 | US20030109563 Combating nematodes characterized in that trifluorobutenes of the formula (I) are allowed to act on nematodes and/or their habitat. |
| 06/12/2003 | US20030109527 Novel hydroxy diphenylurea sulfonamides, compositions and intermediates thereof. The hydroxy |
| 06/12/2003 | US20030109505 Medicament for the treatment of diseases caused by parasitic protozoa |
| 06/12/2003 | US20030109497 Novel imidazolidine derivatives, their preparation and their use |
| 06/12/2003 | US20030109463 Novel macrolides |
| 06/12/2003 | US20030109437 Peptides and methods of treating conditions requiring removal or destruction of harmful or unwanted cells in a patient, such as benign and malignant tumors, using proteins (and peptides derived from the amino acid sequences of such |
| 06/12/2003 | US20030108928 MID 241 receptor, a novel G-protein coupled receptor |
| 06/12/2003 | CA2469385A1 Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, their use as medicament, and medicament containing them |
| 06/12/2003 | CA2469224A1 Trioxane derivatives |
| 06/12/2003 | CA2469223A1 Trioxane derivatives as antimalaria or anticancer compounds |
| 06/12/2003 | CA2468907A1 Effectors of innate immunity |
| 06/12/2003 | CA2467486A1 Vaccine |
| 06/12/2003 | CA2467435A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 06/12/2003 | CA2466570A1 Aminoacetonitrile derivatives and their use for controlling parasites |
| 06/11/2003 | EP1317922A1 Antipyretic preparation containing xylitol |
| 06/11/2003 | EP1317562A2 Test systems based on transmembrane receptors from helminths and the use thereof for identifying and characterizing compounds |
| 06/11/2003 | EP1317486A1 Interferon-alpha induced gene |
| 06/11/2003 | EP1317443A2 Chemokine receptor binding heterocyclic compounds |
| 06/11/2003 | EP1317432A1 Piperidine derivatives for use as 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 06/11/2003 | EP1317424A2 Polyamine analogues as therapeutic and diagnostic agents |
| 06/11/2003 | EP1317282A2 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS |
| 06/11/2003 | EP0996614B1 Acrylonitrile compounds, process for their production and pesticides containing them |
| 06/11/2003 | CN1423700A Multifunctional polypeptides comprising a binding site to and epitope of the NKG2D receptor complex |
| 06/11/2003 | CN1423657A Inter feron-alpha induced gene |
| 06/11/2003 | CN1423646A Hetero cyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 06/11/2003 | CN1423557A Intracorporeal medicaments for photodynamic treatment of disease |
| 06/11/2003 | CN1422849A 吲唑衍生物 Indazole derivative |
| 06/11/2003 | CN1422611A Albendazole lipid and method for preparing said lipid by neutralization method |
| 06/10/2003 | US6576661 Active ingredient combination having insecticidal and acaricidal characteristics |
| 06/10/2003 | CA2413024A1 Antipyretic preparation containing xylitol |
| 06/05/2003 | WO2003045363A2 Treatment of th2 dominated immunological disease states with progesterone receptor antagonists |
| 06/05/2003 | WO2003045319A2 Targeted therapeutics and uses thereof |
| 06/05/2003 | WO2003045318A2 Manipulation of cytokine levels using cd83 gene products |
| 06/05/2003 | WO2003011266A3 Azalide antibiotic compositions |
| 06/05/2003 | WO2002069949A3 Combination therapy for reduction of toxycity of chemotherapeutic agents |
| 06/05/2003 | US20030104478 Screening modulators of g-protein activity: for use in treatment of nervous system disorders |
| 06/05/2003 | CA2466845A1 Manipulation of cytokine levels using cd83 gene products |
| 06/05/2003 | CA2465846A1 Targeted therapeutics and uses thereof |
| 06/04/2003 | EP1315809A2 Control of crop pests and animal parasites through direct neuronal uptake |
| 06/04/2003 | EP1315800A2 Human proteases |
| 06/04/2003 | EP1315727A2 7-oxo pyridopyrimidines |
| 06/04/2003 | EP1315704A1 2-guanidino-4-aryl-quinazoline |
| 06/04/2003 | EP1171108B1 Combination preparation for treating malaria |
| 06/04/2003 | EP1165565B1 Optically pure camptothecin analogues |
| 06/04/2003 | EP1119256B1 Oral combination of lufenuron and nitenpyram against fleas |
| 06/04/2003 | EP0665752B1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof |
| 06/04/2003 | CN1422273A 1,5-disubstituted-3,4-dihydro-1H-pyrimido [4,5-D] pyrimidi-2-one compounds and their use in treating CSBP/P38 kinase mediated diseases |
| 06/04/2003 | CN1422262A 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors |
| 06/04/2003 | CN1422158A Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response |
| 06/04/2003 | CN1421199A Veterinary emulsion injection containing parasiticide prepared via micropowder crystallization process |
| 06/03/2003 | US6573248 Monocyclic L-nucleosides, analogs and uses thereof |
| 06/03/2003 | US6572858 Uses for anti-malarial therapeutic agents |
| 06/03/2003 | CA2103906C Iloprost with action against cerebral malaria |
| 05/30/2003 | WO2003044524A2 Methods and means for influencing intracellular communication and intracellular organelle transport |
| 05/30/2003 | WO2003044021A2 Substituted indolizine-like compounds and methods of use |
| 05/30/2003 | WO2003044010A1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity |
| 05/30/2003 | WO2003043979A2 Pharmaceutically active compounds and methods of use thereof |
| 05/30/2003 | WO2003043622A1 Substituted bicyclo[3.3.1]nonan-2,4,9-triones as pharmaceutical active ingredients |
| 05/30/2003 | WO2003043418A1 Anti-pathogenic composition useful in blood preservation |
| 05/30/2003 | WO2003043416A2 Methods and reagents for the control of infestations of parasites |
| 05/30/2003 | WO2002096952A3 Conjugate of a transport protein and a protein for modulation of notch signalling |
| 05/30/2003 | WO2002095029A3 Nucleic acid and protein sequences of bovine epidermal growth factor |
| 05/30/2003 | WO2002078718A3 Compositions, methods and apparatuses for singlet oxygen delivery |
| 05/30/2003 | WO2002078698A3 Polarisation of dendritic cells (treatment of infections, cancer and autoimmune diseases) using histamine |
| 05/30/2003 | WO2002076485A3 Vaccine for modulating between t1 and t2 immune responses |
| 05/30/2003 | WO2002042284A1 Dibenzosberanyl piperazine derivatives and drug-resistance overcoming agents containing the derivatives |
| 05/30/2003 | CA2506616A1 Substituted bicyclo[3.3.1]nonan-2,4,9-triones as pharmaceutical active ingredients |
| 05/30/2003 | CA2467856A1 Anti-pathogenic composition useful in blood preservation |
| 05/30/2003 | CA2467827A1 Methods and reagents for the control of infestations of parasites |
| 05/30/2003 | CA2466072A1 Substituted indolizine-like compounds and methods of use |
| 05/30/2003 | CA2429539A1 Dibenzosberanyl piperazine derivatives and drug-resistance overcoming agents containing the derivatives |
| 05/29/2003 | US20030100742 Erythromycin a derivatives |
| 05/29/2003 | US20030100588 Indole-type inhibitors of p38 kinase |
| 05/29/2003 | US20030100518 13-Methyl erythromycin derivatives |
| 05/29/2003 | US20030100510 Crystallized structure of type IV collagen NC1 domain hexamer |
| 05/29/2003 | US20030099668 Comprises loading (transfection) immunogenic DNA oligonucleotides for enhanced lymphocyte response; genetic engineering |
| 05/28/2003 | EP1314039A2 Method for identifying peptides that can be specifically cleaved and the use of peptide sequences of this type |
| 05/28/2003 | EP1313512A1 Vascular endothelial growth factor 2 |
| 05/28/2003 | EP1313491A1 Bioactive fraction of eurycoma longifolia |
| 05/28/2003 | EP1313461A2 The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 05/28/2003 | EP1200112B1 Chemokine binding protein of gammaherpesvirus 68 and methods of use therefor |
| 05/28/2003 | EP0973763B1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |
| 05/28/2003 | EP0918517B1 Composition of micro-organisms containing omega-3-fatty acid useful as a prophylactic or therapeutic agent against coccidiosis of animals |
| 05/28/2003 | EP0888352B1 Fused imidazole derivatives as multidrug resistance modulators |
| 05/28/2003 | CN1420884A 2-substd. 4-heteroaryl-pyrimidines and their use in treatment of proliferative disorders |
| 05/28/2003 | CN1420881A Beta-amino acid derivs. as inhibitors of matrix metalloproteases and TNF-alpha |
| 05/28/2003 | CN1420784A Vaccine for treatment of tubercolosis and other intracellular infections diseases and preparing process thereof |
| 05/28/2003 | CN1420779A Nucleoside analogs with carboxamidine-modified bicyclic base |
| 05/28/2003 | CN1420125A Trichina antigen gene Ts 87 and use thereof |
| 05/28/2003 | CN1109546C Compound antimalarial medicine contg. artemisinins medicines and malaridine |
| 05/28/2003 | CN1109544C Beta-alkoxyacrylates against malaria |
| 05/27/2003 | US6569890 Cyclic AMP-specific phosphodiesterase inhibitors |
| 05/27/2003 | US6569886 Parasiticides |
| 05/27/2003 | US6569881 Substituted benzimidazole, the production thereof and the use thereof as means against parasitic protozoa |
| 05/27/2003 | US6569871 Substituted imidazole compounds |